Test Price
2,800 AED✅ Home Collection Available
ACTC1 Gene Cardiomyopathy (Dilated Type 1R) Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
• 99.9% Diagnostic Sensitivity – ISO 9001:2015 accredited processing guarantees unmatched precision for ACTC1 variant detection.
• VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection – Included daily from 8 AM to 11 PM.
• Telephonic Post-Test Clinical Guidance – Expert result interpretation and counselling session provided at no extra cost.
• Insurance & Direct Billing – Quick verification via WhatsApp | +971 54 548 8731
Test Overview & Methodology
The ACTC1 NGS test analyses the entire coding region of the ACTC1 gene to identify pathogenic variants linked to dilated cardiomyopathy type 1R. It provides a definitive molecular diagnosis for inherited cardiomyopathy, enabling early clinical intervention and family screening. The methodology combines Next‑Generation Sequencing (NGS) with Sanger confirmation for variant validation.
| Feature | Our ACTC1 NGS Test | Closest Alternative (Standard Panel) |
|---|---|---|
| Target Precision | Full gene sequencing with deep coverage (≥100x), allele-specific analysis | Multi-gene panel; may miss rare deep intronic or copy number variants |
| Methodology | Next‑Generation Sequencing (NGS) + Sanger confirmation | NGS panel; variant validation often not included |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks |
| Clinical Actionability | Direct correlation to dilated cardiomyopathy type 1R, family risk stratification | Broad risk estimation; uncertain significance for some genes |
Physician Insight & Safety Protocols
“As a genetic consultant, I understand the emotional weight of genetic risk. This test illuminates hereditary factors but must always be interpreted together with imaging and family history. Please never stop your medications abruptly; your cardiologist will guide every step.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Safety Advisory
⚠ Medication Safety Notice
Do not discontinue any prescribed heart or blood pressure medication based on genetic test results. Always consult your treating physician before making changes.
Exclusion Criteria & Emergency Red Flags
Exclusion Criteria
- Minors without legal guardian consent (as per UAE Federal Laws).
- Patients unable to provide informed consent or attend mandatory genetic counselling.
- Emergency signs: new‑onset chest pain, syncope, severe shortness of breath, or palpitations – seek immediate emergency care.
Patient FAQ & Clinical Guidance
1. What is the ACTC1 gene cardiomyopathy (dilated type 1R) NGS test?
This specialised genetic test uses Next‑Generation Sequencing to detect disease‑causing mutations in the ACTC1 gene, confirming dilated cardiomyopathy type 1R. The analysis reads every coding base, identifying even low‑frequency variants that standard panels might overlook.
2. Who should consider this genetic test?
Anyone with a personal or family history of unexplained dilated cardiomyopathy, young‑onset heart failure, or sudden cardiac death should strongly consider testing. Cardiologists, sports scientists assessing athletes, and medical researchers often request it for definitive risk stratification. UAE regulations require pre‑test genetic counselling, which we provide as part of the service.
3. How are the results interpreted and what are the next steps?
A positive result indicates a known pathogenic variant, guiding personalised surveillance and family cascade testing; a negative result reduces but does not eliminate risk. Inconclusive findings may require further investigation. Our telephonic clinical guidance session explains the implications in plain language and helps coordinate follow‑up with your specialist.
UAE Regulatory & Data Privacy Adherence
🏆 Regulatory & Quality Assurances
Licensed by Dubai Health Authority (DHA Facility License No. 1143). All genetic testing adheres to Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent follow Federal Decree‑Law No. 4 of 2016 on Medical Liability. Testing laboratory holds ISO 9001:2015 certification (Cert: INT/EGQ/2509DA/3139), ensuring globally benchmarked quality.
Clinical & Logistical Metadata
| Test Name | ACTC1 Gene Cardiomyopathy (Dilated Type 1R) Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole Blood (Peripheral) – VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection Available (8 AM – 11 PM) |
| Methodology Used | Next‑Generation Sequencing (NGS) + Sanger Confirmation |
| ICD-10-CM Code | I42.0 |
| LOINC Code | 85145-6 |
| DHA Facility License & Laboratory Address | License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians